DRUG DELIVERY SYSTEMS AND ROUTES OF ADMINISTRATION OF PEPTIDE AND PROTEIN DRUGS

被引:44
作者
SANDERS, LM
机构
[1] Syntex Research, Palo Alto, 94303, CA
关键词
controlled release; delivery routes; Peptide delivery; protein delivery; protein formulation; systemic delivery;
D O I
10.1007/BF03190192
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The unique requirements of peptides and proteins in designing delivery systems, and the unprecedented recent growth in the field, has driven a great deal of research into novel means of drug delivery. The search for approaches that provide formulations that are stable, bioavailable, readily manufacturable, and acceptable to the patient, has led to major advances in development of nasal and controlled release technology. The field of parenteral solution technology has also seen some new demands made of it, and what was formerly a conventional area of formulation technology has made scientific advances to meet the needs of these compounds. At the same time, strides are being made in fundamental research in areas including oral delivery, transdermal delivery, and pulsatile and 'on demand' delivery of peptides and proteins. © 1990 Springer-Verlag.
引用
收藏
页码:95 / 102
页数:8
相关论文
共 32 条
[1]   PRELIMINARY-REPORT ON USE OF DEPOT FORMULATION OF LHRH ANALOG ICI 118630 (ZOLADEX) IN PATIENTS WITH PROSTATIC-CANCER [J].
AHMED, SR ;
GRANT, J ;
SHALET, SM ;
HOWELL, A ;
CHOWDHURY, SD ;
WEATHERSON, T ;
BLACKLOCK, NJ .
BRITISH MEDICAL JOURNAL, 1985, 290 (6463) :185-187
[2]   SYSTEMIC DELIVERY OF THERAPEUTIC PEPTIDES AND PROTEINS [J].
BANGA, AK ;
CHIEN, YW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1988, 48 (1-3) :15-50
[3]  
BURNS R, 1990, IN PRESS J CONT REL
[4]  
DAVIDSON GWR, 1988, 15TH P INT S CONT RE, P66
[5]  
DAVIS SS, 1986, DELIVERY SYSTEMS PEP, P1
[6]  
EPPSTEIN DA, 1988, CRC CR REV THER DRUG, V5, P99
[7]  
EPPSTEIN DA, 1986, BIOL INTERFERON SYST
[8]  
EPPSTEIN DA, 1986, TARGETING DRUGS SYNT, P207
[9]  
EPPSTEIN DA, 1986, DELIVERY SYSTEMS PEP, P277
[10]  
GOOSEN MFA, Patent No. 134318